Department of Biosciences and Nutrition, Karolinska Institutet, Neo, 141 57 Huddinge, Sweden.
RISE, Department Chemical Process and Pharmaceutical Development, Forskargatan 18, 151 36 Södertälje, Sweden.
Molecules. 2021 Nov 17;26(22):6927. doi: 10.3390/molecules26226927.
2'--(-(Aminoethyl)carbamoyl)methyl-modified 5-methyluridine (AECM-MeU) and 5-methylcytidine (AECM-MeC) phosphoramidites are reported for the first time and prepared in multigram quantities. The syntheses of AECM-MeU and AECM-MeC nucleosides are designed for larger scales (approx. 20 g up until phosphoramidite preparation steps) using low-cost reagents and minimizing chromatographic purifications. Several steps were screened for best conditions, focusing on the most crucial steps such as N and/or 2'-OH alkylations, which were improved for larger scale synthesis using phase transfer catalysis (PTC). Moreover, the need of chromatographic purifications was substantially reduced by employing one-pot synthesis and improved work-up strategies.
2'--(-(氨乙基)碳酰胺基)甲基修饰的 5-甲基尿苷(AECM-MeU)和 5-甲基胞苷(AECM-MeC)磷酰胺被首次报道,并以多克数量级制备。AECM-MeU 和 AECM-MeC 核苷的合成设计用于更大规模(约 20 克,直到磷酰胺制备步骤),使用低成本试剂和最小化的色谱纯化。筛选了几个步骤以获得最佳条件,重点关注最关键的步骤,如 N 和/或 2'-OH 烷基化,使用相转移催化(PTC)对其进行了改进,以适应更大规模的合成。此外,通过一锅合成和改进的后处理策略,大大减少了色谱纯化的需求。